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ORIGINAL ARTICLE
Bone-Anchored Hearing Aid Implant Location
in Relation to Skin Reactions
Hubert T. Faber; Maarten J. F. de Wolf, MD; Jacky W. J. de Rooy; Myrthe K. S. Hol, MD, PhD;
Cor W. R. J. Cremers, MD, PhD; Emmanuel A. M. Mylanus, MD, PhD
Objective: To evaluate the effect of implant location and
skin thickness on the frequency and degree of adverse
skin reactions around the abutment.
Design: Retrospective multivariate analysis of implant
position related to skin thickness and clinical variables.
Setting: Tertiary referral center.
Patients: Random sample of 248 patients with bone-
anchored hearing aids.
Interventions: Bone-anchored hearing aid implant place-
ment by means of the linear incision technique.
Mean OutcomeMeasures: Type and number of skin
reactions and implant loss.
Results: The mean (SD) distance from the external au-
ditory ear canal to implant was 48.8 (8.0) mm (range,
29-84 mm). The mean skin thickness was 5.5 (1.9) mm.
Severe skin reactions (Holgers classification, 2-4) were
seen in 46 of the 248 patients (18.5%). Implant loss oc-
curred in 4 patients (1.6%). Three implants were lost
owing to failed osseointegration (1.3%), and another
implant was removed because of deterioration of coch-
lear function (0.9%). No implant was lost as a result of
infection.
Conclusion: Implant location and skin thickness were
not correlated with implant loss or the frequency or de-
gree of adverse skin reactions around the abutment.
Arch Otolaryngol Head Neck Surg. 2009;135(8):742-747
B RÅNEMARK ET AL
1 FIRST DE-
scribed the principle of os-
seointegrated implantation in
the dental region. On the ba-
sis of osseointegration be-
tween bone and titanium, a new hearing de-
vice was introduced, the bone-anchored
hearing aid (BAHA).2 Tjellström et al3 ini-
tiated the first clinical applicationofaBAHA
device coupled to a skin-penetrating, bone-
anchoredtitaniumimplant (anchoredto the
temporal bone of the skull). The implant
in the skull enables sound vibrations to be
transmitted to the cochlea via bone con-
duction. Since 1987, the BAHA system has
beensuccessfully introduced inmanycoun-
tries. In the Netherlands, the BAHA pro-
gramwasestablishedat theUniversityMedi-
cal Center in Nijmegen in 1988. In patients
with conductive or mixed hearing loss, the
BAHA has been a well-established treat-
ment for over 25 years.4,5
One of the main concerns in BAHA sur-
gery is to achieve a stable implant with a
zone of reaction-free skin around the per-
cutaneous abutment. It has been reported
that movement of the tissue around the per-
cutaneous implant it is a risk factor for skin
reactions.6 Surgical thinning of the skin
around the abutment reduces the chance
of epithelial debris or crusts being trapped
between the abutment and the skin and act-
ing as foreign bodies.
Regular cleaning is the most effective
way to prevent skin reactions. If skin re-
actions occur, they can usually be treated
successfully with a medicated ointment.
Skin reactions should be avoided because
they can have a more serious outcome,
such as skin overgrowth, implant extru-
sion, and severe wound infection.7-9 The
probability of losing an implant as a re-
sult of adverse skin reactions is fairly low.
However, if left untreated, a skin reac-
tion may eventually lead to implant loss
or withdrawal.10 Also, preexisting skin im-
pairment, such as dermatoses, thick skin,
previous radiotherapy, and poor hy-
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giene, can impair the clinical outcome.6,11,12 Other fac-
tors that might influence the long-term results are soft-
tissue reduction during BAHA surgery and the implant
location on the skull, which might also influence soft tis-
sue in the long term. We evaluated the effect of the im-
plant location and skin thickness on the frequency and
degree of adverse skin reactions around the abutment.
METHODS
PATIENTS
Patients who were scheduled for their regular (yearly)
follow-up visit to the BAHA outpatient clinic were invited to
participate in the study. Inclusion criteria were age older than
17 years, implant using the Nijmegen linear incision tech-
nique, unilateral application, and at least 1 year of BAHA use.
Patients with syndromic features and skull deformities were
excluded. The patients were informed about the study,
including the skin thickness measurement using a needle and
the lateral skull radiograph. A random sample of 248 patients
agreed to participate in the study. They had undergone
implantation during the period of January 1, 1992, through
December 31, 2006.
BAHA SURGERY
All the patients had received their BAHA using the Nijmegen
linear incision technique. In general, the Nijmegen linear in-
cision technique consists of a longitudinal incision approxi-
mately 3 cm long, 50 to 55 mm posterosuperiorly to the ear
canal. After removal of the periosteum, the titanium implant
was placed according to the 1-stage technique described by Tjell-
ström and Granström.13 Subcutaneous tissue was reduced ex-
tensively over an area of approximately 2 cm around the inci-
sion. After wound closure, a pressure dressing provided
hemostasis. The handling of the soft tissue is described by de
Wolf et al14 and was not modified during the study period.
SKIN THICKNESS
MEASUREMENTS
Skin thickness at the implant site was estimated by using a needle
to penetrate the skin up to the bone on the contralateral side
at the matching position (relative distance of the implant from
the ipsilateral rim and pinna). The procedure was performed
by 2 otolaryngologists (E.A.M.M. and M.K.S.H.). Measure-
ments were recorded as the number of millimeters the needle
penetrated the skin during the regular checkups.
IMPLANT POSITION
A standardized digital lateral conventional radiograph of the
whole skull (Siemens, Erlangen, Germany), taken of the ipsi-
lateral side of the implant, was used to determine the position
of the implant on the skull. The side of the implant was always
positioned nearest to the x-ray detector to avoid differences in
the magnification factor. The distance from the upper center
of the external auditory ear canal to the implant was measured
using the ruler function in a radiological program, with the
Frankfurter horizontal plane (FHP) as a baseline (adopted at
the 1884 Craniometrical Conference in Frankfurt am Main, Ger-
many, cited in 1958 by Moorrees and Kean15). It consists of a
straight line between the most superior point on the upper mar-
gin of the external auditory ear canal and the most inferolat-
eral point in the orbital cavity (Figure 1). The position of the
implant was recorded as x- and y-coordinates (horizontal and
vertical, respectively) using the FHP as the x-axis.
CASE ANALYSIS
Data were retrieved from the medical records. These include
age, sex, indication for a BAHA, surgical method, type of im-
plant (3 or 4 mm), type of abutment (5.5 or 8.5 mm), type of
tissue at the end of the drilled hole, implant loss, duration un-
til loss, skin reactions (according to the classification pub-
lished by Holgers et al,16 hereinafter Holgers classification), time
of implantation, and duration of follow-up.
FOLLOW-UP
The tissue reactions around the abutment were evaluated ac-
cording to the Holgers classification: grade 0, no reaction; grade 1,
reddish discoloration of the skin around the implant; grade 2,
red and moist surface of the skin around the implant; grade 3,
formation of granulation tissue around the implant; and grade 4,
extensive soft-tissue reaction that requires implant removal or
leads to implant loss.16 The state of the skin around the im-
plant was also observed. Thick skin around the implant was
noted when it was level with the top of most of the abutment.
At each follow-up visit, the implant stability was checked manu-
ally with a torque wrench. All these data were entered into the
medical files by means of a standardized stamp. Initially, the
patients attended the checkups at least once every 4 months.
Later, the interval was prolonged to 6 months, and currently,
once a year is the standard interval.
STATISTICAL ANALYSIS
Comparisons of categorical variables were made using multi-
variate correlation tests, 1-way analysis of variance, and inde-
pendent sample t tests. Time-to-event analyses were con-
ducted using Kaplan-Meier curves. The analyses controlled for
age at surgery, sex, duration of follow-up, and tissue type at
the end of the hole drilled for the abutment. SPSS software (ver-
sion 16; SPSS Inc, Chicago, Illinois) and Prism Graph Pad 5
(GraphPad Software, La Jolla, California) were used to per-
form statistical analysis. The level of significance was set atP=.05.
x
l
FHP y
Figure 1. Frankfurt horizontal plane (FHP) coordinates of the implant (x- and
y-coordinates) used to measure the distance from the upper center of the
external auditory ear canal to the implant (l). x indicates the distance from
the upper center of the external auditory ear canal (EAEC) to implant along
the FHP; and y, the distance from the upper center of the EAEC to the implant
vertically perpendicular to the FHP.
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RESULTS
DESCRIPTION OF POPULATION
Our population comprised 100 men and 148 women with
a unilateral percutaneous titanium implant. The mean
(SD) age at implantation was 52.5 (14.7) years. Figure2
shows the age distribution. Implants had been placed on
the left side (n=128) and on the right side (n=120). In-
dications for BAHA fitting were bilateral acquired con-
ductive or mixed hearing loss (n=209 patients [86.7%]),
congenital conductive hearing loss (n=8 [3.8%]), and uni-
lateral inner ear deafness (n=31 [12.5%]). The latter group
comprised 30 cases of acoustic neurinoma and 1 case of
intracranial rhabdomyoma. The etiology of the hearing
loss in 1 patient (0.4%) was trauma. A total of 12 pa-
tients were classified as having mental retardation.
A 1-stage surgical procedure had been used to place
247 implants (99.6%). In 1 patient, the second stage (abut-
ment placement and tissue reduction) was performed
separately.
During surgery, the drilled hole had ended in bone
in 213 cases (85.9%), at the dura mater in 21 cases (8.5%),
and in the sinus in 8 cases (3.2%). Only 6 observations
were missing (2.4%). All of the implants were 4 mm ex-
cept for 1. In 2 cases, the length of the implant was not
noted in the medical records. All the abutments were 5.5
mm except for 1. This patient did not report any ad-
verse skin reactions or thick skin. The mean duration of
follow-up was 67.7(39.4) months (range, 12-215 months)
with a mean of 7.4 (4.9) observations per implant.
IMPLANT LOCATION MEASUREMENTS
ON THE LATERAL RADIOGRAPHS
The mean (SD) distance from the upper center of the ex-
ternal auditory ear canal to the implant was 48.8 (8.0)
mm (range, 29.0-84.0 mm), the mean distance of the x-
component was 44.8 (8.5) mm (range, 22.0-82.0 mm),
and the mean distance of the y-component was 18.6 (10.6)
mm (range, −13.0 to 48.0 mm). Figure 3 shows a lat-
eral representation of the scatter of implant positions.
In patients with congenital atresia (n=8), the mean
distance of the y-component was 21.3 mm. Compared
with the mean distance of the y-component in the other
patients (18.5 mm) this was not a notable difference. Their
x-component was 46.3 mm compared with the other pa-
tients, which was not clinically significant. The mean dis-
tance between the upper center of the external auditory
ear canal and implant was 51.5 mm. This difference
(0.3 mm) was not clinically significant compared with
those of the other patients. The measurements in the pa-
tients with congenital atresia did not notably affect the
distances in the total group of patients. In the patients
who had undergone translabyrinthine schwannoma sur-
gery, the x-component of the implant location did not
differ from that in the patients who underwent “regular”
BAHA surgery.
IMPLANT LOSS
A total of 4 of the 244 implants (1.6%) were lost: 3 owing
to failed osseointegration (1.3%) and 1 that was removed
owing to deterioration of cochlear function (0.9%). No im-
plants were lost as a result of infection. Statistical analysis
did not show any relationship between implant loss and
the distance from the upper center of the ear canal to the
implant, the mean distance of the x-component, and the
y-component.
SKIN REACTIONS
Skin reactions were observed in 130 patients (52.4%):
in 84 patients the most severe skin reaction was Holgers
grade 1 (33.9%), in 32 patients this was Holgers grade 2
(12.9%), in 12 patients this was grade 3 (4.8%), and only
2 patients had a grade 4 skin reaction (0.8%). In this group,
46 patients (18.5%) had a skin reaction that required treat-
ment (classified as Holgers grade 2-4). This type of re-
action occurred only once in 33 of the 46 patients (71.7%)
(Table 1 and Table 2).
The mean intervals in months between implantation
and the skin reactions were 42.5 months for grade 1, 37.8
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Figure 2. Age at time of surgery per implant (N=248 patients) and number
of implants.
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Figure 3. Scatterplot of the implant locations. The coordinates
(0,0)=external auditory ear canal (EAEC); x=distance from the upper center
of the EAEC to implant along the Frankfurt horizontal plane (FHP); y=the
distance from the upper center of the EAEC to implant vertically
perpendicular to the FHP.
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months grade 2, 37.8 months for grade 3, and 76.5 months
for grade 4 (Table 3). The mean interval until the first
skin reaction, irrespective of the grade, was 24.3 months
(range, 0-129 months).
The distance from the upper center of the external au-
ditory ear canal to the implant was not correlated with
Holgers grade 1 to 4 skin reactions or the total number
of skin reactions. Furthermore, there was no correla-
tion between skin reactions or implant loss and the x-
and y-components of the distance from the upper cen-
ter of the ear canal to the implant.
SKIN THICKNESS, MEASUREMENTS,
OBSERVATIONS, AND REVISION SURGERY
In 204 patients (82.3%), skin thickness was measured
on the side contralateral to the percutaneous implant. Skin
thickness varied from 2.0 to 11.0 mm, with a mean (SD)
thickness of 5.5 (1.9) mm. Analyses did not show any
statistically significant correlations between skin thick-
ness and implant loss (P =.58), or skin reactions of Hol-
gers grades 1 and 2 (P =.48 and .65, respectively; there
were too few cases of Holgers skin reactions of grades 3
and 4 for statistical comparison), or with the total num-
ber of skin reactions (P=.39). There was no significant
correlation between skin thickness and the vertical com-
ponent (y) (P=.57). However, skin thickness was signifi-
cantly correlated with the horizontal component (x) (0.2
mm; P .002) and the mean distance from the implant
to the ear canal (0.2 mm; P .001).
Next to the measurements of the thickness of the skin
at the contralateral side to the implant, the state of the
skin level around the abutment was recorded during fol-
low-up in 192 patients. Thick skin, that is, skin reach-
ing to the top of the 5.5-mm abutment, had been noted
in 81 patients (42.2%), with a mean rate of 2.4 observa-
tions (range, 1-12 observations). Only 40 patients (16.1%)
had 1 single observation of thick skin. The latter once-
only events accounted for 49.4% of all the observations
of thick skin. The mean (SD) interval until the first ob-
servation of thick skin was 47.0 (33.6) months. In most
of the cases, the thick skin was treated successfully with
antibacterial and steroid ointment or watchful waiting.
Tissue reduction surgery was performed on 23 im-
plants (9.4%) at a mean period of 34 months after im-
plantation (range, 4-119 months) when thick skin per-
sisted. One patient required 1 subsequent tissue reduction
surgery.
COMMENT
We evaluated the effect of the implant location and skin
thickness on the frequency and severity of skin reac-
tions around the abutment. To evaluate this correlation,
the position of the implant (the mean distance from ex-
ternal auditory ear canal to the implant) was measured
(48.3 mm). This corresponds with the ideal site accord-
ing to the Nijmegen BAHA surgical procedure because
it leaves enough space to accommodate the BAHA trans-
ducer behind the auricle.14 No correlation could be found
between implant location and the frequency and sever-
ity of skin reactions in this study.
To our knowledge, no previous studies have investi-
gated a possible correlation between implant location and
skin reactions. Eeg-Olofsson et al,17 however, described
the position of the implant in relation to the external au-
ditory ear canal. Their study was set up to determine the
extent to which bone dampened sound transmission to
the cochlea. They found that moving the vibrating stimu-
lus closer to the cochlea increased the velocity at the coch-
lear promontory. Combined with the results of our study,
the ideal implant site in terms of optimal sound trans-
mission and low incidence of skin reactions would be as
close to the cochlea as possible.
It should be noted that skull dimensions can vary
among individuals. Skull dimensions also change with
Table 1. Clinical Data on Skin Reactions
and Revision Surgery
Scale (Skin Reaction)
No. (%)
Distribution
per Observation
Most Severe Skin
Reaction per Implant
0 (No irritation) 1505 (84.7) 118 (47.6)
1 (Slight redness) 206 (11.6) 84 (33.9)
2 (Red and moist tissue) 52 (2.9) 32 (12.9)
3 (Granulation tissue) 12 (0.7) 12 (4.8)
4 (Infection leading to
removal of abutment)
2 (0.1) 2 (0.8)
Total 1777 (100) 248 (100)
aAccording to the scale described by Holgers et al.16
Table 2. Frequency of Skin Reaction and Most Severe
Skin Reaction Around the Implant
Frequency of
Skin Reactions
Follow-up, No.
No. (%)
Total Adverse
Skin Reactions
per Implant
Total Skin Reactions
Rated as 2-4
per Implanta
0 118 (47.6) 202 (81.5)
1 68 (27.4) 33 (13.3)
2 27 (10.9) 9 (3.6)
3 15 (6.1) 2 (0.8)
4 7 (2.8) 2 (0.8)
5 7 (2.8) 0
6 2 (0.8) 0
7 4 (1.6) 0
Total 248 (100) 248 (100)
aAccording to the scale developed by Holgers et al.16
Table 3. Interval Between Implantation and Skin Reaction
Time to Skin
Reaction
Type, mo
Implants
No. Range Mean (SD)
1 111 0-179 42.5 (34.0)
2 37 0-119 37.8 (35.5)
3 12 1-127 37.8 (39.8)
4 2 48-105 76.5 (40.3)
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advancing age (eg, progressive decrease in the height of
the neurocranium).18,19 Patil and Mody20 described sig-
nificant differences in 10 cephalometric dimensions be-
tween men and women. In the current study, we ad-
justed the statistical analyses for sex and age to address
the differences in skull dimensions.
In BAHA surgery, special attention must be given to
the handling of the soft tissue in order to obtain thin hair-
less skin with optimal reduction of mobility. The soft-
tissue reduction technique used results in a gentle slope
of the soft tissue in an area of approximately 15 to 20
cm2 around the percutaneous implant, depending on the
length of the incision. At the basis of the abutment, post-
operatively the skin thickness varies from approxi-
mately 1 to 1.5 mm. Unfortunately, because skin thick-
ness measurements at the implant location were not
performed in a structural manner, a prospective analy-
sis was not possible.
Implant loss is one of the major clinical outcome mea-
sures in BAHA surgery. In our study, the total implant
loss was 1.6% (4 of the 248 implants). Recent studies by
the Nijmegen BAHA team reported a 9.3% implant loss
(14 of 150 implants) in a consecutive series of 142 pa-
tients who had undergone BAHA surgery and in 6.5% (14
of 248 implants) in 224 elderly patients who had under-
gone BAHA surgery.14,21 In the literature, implant loss
caused by failed osseointegration ranged from 0.4% to
7%, whereas loss caused by infection ranged from 0.4%
to 2.7%.5,7,9,10,22,23 The mean (SD) duration of follow-up
in the current study was 78.4 (48.3) months (range, 12-
220 months) compared with a range of 6 to 141 months
in the literature.5,7,10,22 Rates of implant loss in these Ni-
jmegen series are substantially lower than those de-
scribed in literature.
An explanation for the differences in implant loss might
lie partly in the exclusion of children from this study.
Compared with the adult skull, the infant skull is less
thick and has less mineral content and more water con-
tent. This is believed to be one of the causes of the higher
risk of failed osseointegration in the younger popula-
tion.7 In the study by Proops,22 implant loss occurred in
19 of 188 patients (10.1%); 10 of these 19 (52.6%) oc-
curred in children. In the Nijmegen consecutive series
of children,24 implant loss in children also accounted for
a relatively large part of the percentage. Overall implant
loss in the Nijmegen series24 was 16.3% (21 of 129).
Another major clinical outcome measure in the fol-
low-up after BAHA surgery is skin reactions. Our data
showed that 46 of the 248 patients (18.5%) had a severe
skin reaction (Holgers grade, 2-4) at least once during
follow-up. In this group of patients, 33 (71.7%) had a
severe skin reaction only once. The rates of severe skin
reactions in the current study conform with those in the
literature (3.4%-39.6%).5,10,16,25-27 These data are also in
line with those of previous studies performed within
the BAHA program at the University Medical Centre.
de Wolf et al14 found an incidence of 26.7% (40 of 150)
in a consecutive series of patients with BAHA implants.
Besides implant location, another potentially rel-
evant variable is skin thickness. Measurements found in
this study varied from 2.0 to 11.0 mm, with a mean (SD)
thickness of 5.5 (1.9) mm. No correlations were found
between skin thickness and implant loss, Holgers grade
1 to 4 skin reactions, the y-component, or the total num-
ber of skin reactions. Measurements of the skin thick-
ness were taken on the side contralateral to the implant.
Skin thickness was significantly positively correlated with
the x-component and the distance between the implant
and the ear canal (0.22 mm, P .002; and 0.24 mm,
P .001, respectively). Thus, the greater the distance be-
tween the implant and the ear canal, the thicker the skin.
The procedure used for skin thickness measurements was
based on the assumption that the skin is of equal thick-
ness on both sides.
In conclusion, no correlations were found between
the distance from the superior part of the external audi-
tory ear canal to the implant nor between the horizontal
and vertical positions of the implant and the type and
number of skin reactions. Skin thickness measured on
the contralateral side was not correlated with the type
and number of skin reactions. Comparatively, implant
loss was not correlated with the distance from the supe-
rior part of the upper center of the external auditory ear
canal to the implant, the position of the implant, or skin
thickness.
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